These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14581)

  • 21. The effect of cannabichromene on mean blood pressure, heart rate, and respiration rate responses to tetrahydrocannabinol in the anesthetized rat.
    O'Neil JD; Dalton WS; Forney RB
    Toxicol Appl Pharmacol; 1979 Jun; 49(2):265-70. PubMed ID: 494278
    [No Abstract]   [Full Text] [Related]  

  • 22. Interactions of active constituents of marihuana with other drugs in the neuron.
    Dewey WL; Johnson KM; Bloom AS
    Ann N Y Acad Sci; 1976; 281():190-7. PubMed ID: 798522
    [No Abstract]   [Full Text] [Related]  

  • 23. Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors.
    Westlake TM; Howlett AC; Ali SF; Paule MG; Scallet AC; Slikker W
    Brain Res; 1991 Mar; 544(1):145-9. PubMed ID: 1649662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
    Carta G; Nava F; Gessa GL
    Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cannabinoids, cannabinoid receptor and immune response].
    Yan MS; Lian ML; Huang JS
    Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):261-4. PubMed ID: 12545719
    [No Abstract]   [Full Text] [Related]  

  • 26. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
    Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
    Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.
    Thomas BF; Lefever TW; Cortes RA; Grabenauer M; Kovach AL; Cox AO; Patel PR; Pollard GT; Marusich JA; Kevin RC; Gamage TF; Wiley JL
    J Pharmacol Exp Ther; 2017 Apr; 361(1):162-171. PubMed ID: 28087785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.
    Wang L; Liu J; Harvey-White J; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1393-8. PubMed ID: 12538878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.
    Cook SA; Lowe JA; Martin BR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1150-6. PubMed ID: 9618417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional interaction and cross-tolerance between ethanol and Δ9-THC: possible modulation by mouse cerebellar adenosinergic A1/GABAergic-A receptors.
    Dar MS
    Behav Brain Res; 2014 Aug; 270():287-94. PubMed ID: 24875771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between delta-9-tetrahydrocannabinol and indomethacin.
    Green K; Kearse EC; McIntyre OL
    Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designer Drugs 2.0.
    Huestis MA; Tyndale RF
    Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew).
    Rock EM; Parker LA
    Behav Neurosci; 2015 Jun; 129(3):368-70. PubMed ID: 26030435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of delta9-tetrahydrocannabinol on cell proliferation and macromolecular biosynthesis in human cells.
    Mon MJ; Jansing RL; Doggett S; Stein JL; Stein GS
    Biochem Pharmacol; 1978; 27(13):1759-65. PubMed ID: 708456
    [No Abstract]   [Full Text] [Related]  

  • 35. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice.
    Wiley JL; Smith FL; Razdan RK; Dewey WL
    Eur J Pharmacol; 2005 Mar; 510(1-2):59-68. PubMed ID: 15740725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones.
    Millns PJ; Chapman V; Kendall DA
    Br J Pharmacol; 2001 Mar; 132(5):969-71. PubMed ID: 11226126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects.
    Tashkin DP; Reiss S; Shapiro BJ; Calvarese B; Olsen JL; Lodge JW
    Am Rev Respir Dis; 1977 Jan; 115(1):57-65. PubMed ID: 319717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of delta9-tetrahydrocannabinol on the disposition of d-amphetamine in the rat.
    Siemens AJ
    Life Sci; 1977 Jun; 20(11):1891-904. PubMed ID: 875626
    [No Abstract]   [Full Text] [Related]  

  • 39. delta 9-Tetrahydrocannabinol inhibits human sperm motility.
    Hong CY; Chaput de Saintonge DM; Turner P
    J Pharm Pharmacol; 1981 Nov; 33(11):746-7. PubMed ID: 6118422
    [No Abstract]   [Full Text] [Related]  

  • 40. Perfusion of the isolated rat brain with [14C]-delta1-tetrahydrocannabinol.
    Martin B; Agurell S; Krieglstein J; Rieger H
    Biochem Pharmacol; 1977 Dec; 26(23):2307-9. PubMed ID: 588312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.